CELECOR THERAPEUTICS
Live / Applied — First extension granted (statement of use) (as of 02 Apr 2026)
What this means for you
Not registered yet, but its 13 Sept 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98749323
- Mark type
- Design + words
- Filed
- 13 Sept 2024
- Published for opposition
- 10 Jun 2025
- Attorney of record
- Christina M. Licursi
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and therapeutics for the treatment of cardiovascular disease
- Class 042 — Scientific and technological services: Scientific research, pharmaceutical research, medical research; technical scientific consultation and product development for others in the field of biotechnology and development of pharmaceuticals
Owner
- CeleCor Therapeutics, Inc., Del Mar, CA, US
- CeleCor Therapeutics, Inc., Del Mar, CA, US
Prosecution history
- 03 Apr 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Apr 2026 — SOU EXTENSION 1 GRANTED
- 02 Apr 2026 — SOU EXTENSION 1 FILED
- 02 Apr 2026 — SOU TEAS EXTENSION RECEIVED
- 07 Oct 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 10 Jun 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Jun 2025 — PUBLISHED FOR OPPOSITION
- 04 Jun 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 12 May 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 06 May 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 06 May 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 06 May 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 17 Mar 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 17 Mar 2025 — NON-FINAL ACTION E-MAILED
- 17 Mar 2025 — NON-FINAL ACTION WRITTEN